Topic: Alexza Pharmaceuticals Inc.

Biotech Stock Live Chat Welcome to December's Biotech Stock Mailbag Live Chat. The floor is yours. I'm here for the next 90 minutes to answer your...

Pharma News: Alexza Pharmaceuticals, YM BioSciences

Alexza Pharmaceuticals (ALXA) said today the U.S. Food and Drug Administration's psychopharmacologic advisory committee voted to recommend its...
Alexza Pharmaceuticals (NASDAQ: ALXA)'s stock had its "outperform" rating reaffirmed by equities research analysts at JMP Securities in a research...
Posted on 10/24/11 at 9:03am by Eddie Staley . Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that the U.S. Food & Drug...

The BioTech Bounce: Alexza Pharma

Posted on 08/12/11 at 3:34pm by Michael J. Zerinskas . Biotech stocks are often one of the first subsectors to bounce in a bear market and/or harsh...
Posted on 08/05/11 at 8:32am by Eddie Staley . Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it has resubmitted its AZ-004 New...
Posted on 03/15/11 at 3:02am by Monica Gerson . AAR Corp (NYSE: AIR ) is projected to report its Q3 EPS at $0.42 on revenue of $447.38 million.....
The FDA showed it was playing hardball this October by delivering two completes response letters (CRLs) last Friday - one to Jazz Pharmaceuticals...
MO, Oct. 11 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA) for AZ-004 (Staccato loxapine), submitted ...

Alexza Pharma Still Has Room to Rise

With an FDA decision due in early October, Alexza Pharmaceuticals' (ALXA) stock has been reacting very nicely in anticipation, making a string of higher highs and higher lows since early August.. Last week, the Company issued a press release announcing that it ...